Cherokee Health Systems

Cherokee Health Systems

Services:
Language Services
• Sign language services for the deaf and hard of hearing

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• No formal relationship with prescribing entity

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders

Assessment/Pre-treatment

• Screening for substance use
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use
• Comprehensive mental health assessment
• Complete medical history/physical exam

Transitional Services

• Aftercare/continuing care
• Naloxone and overdose education

Education and Counseling Services

• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Family counseling
• Marital/couples counseling
• Hepatitis education, counseling, or support
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Group counseling

Recovery Support Services

• Mentoring/peer support
• Housing services
• Recovery coach
• Assistance with obtaining social services

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Type of Opioid Treatment

• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization
• Prescribes naltrexone

Gender Accepted

• Female
• Male

Treatment Approaches

• Substance use disorder counseling
• Relapse prevention
• Anger management
• Trauma-related counseling
• Motivational interviewing
• Cognitive behavioral therapy
• Brief intervention
• Telemedicine/telehealth therapy

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

License/Certification/Accreditation

• State Substance use treatment agency
• Federally Qualified Health Center
• State mental health department

Pharmacotherapies

• Acamprosate (Campral®)
• Buprenorphine (extended-release, injectable)
• Nicotine replacement
• Non-nicotine smoking/tobacco cessation
• Medications for pre-exposure to prophylaxis
• Medication for mental disorders
• Naltrexone (extended-release, injectable)
• Naltrexone (oral)
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Disulfiram

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Medical Services

• Hepatitis A (HAV) vaccination
• Hepatitis B (HBV) vaccination

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Ancillary Services

• Mental health services
• Integrated primary care services
• Case management service
• Transportation assistance
• Early intervention for HIV

Other Services

• Treatment for other addiction disorder

Testing

• Testing for Hepatitis B (HBV)
• Metabolic syndrome monitoring
• STD testing
• Drug or alcohol urine screening
• HIV testing
• Testing for Hepatitis C (HCV)
• TB screening

Facility Smoking Policy

• Smoking permitted in designated area

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Payment/Insurance/Funding Accepted

• State-financed health insurance plan other than Medicaid
• Federal military insurance (e.g., TRICARE)
• Medicaid
• Federal, or any government funding for substance use treatment programs
• Private health insurance
• SAMHSA funding/block grants
• Cash or self-payment
• Medicare

Facility Vaping Policy

• Vaping permitted in designated area